Transcenta inks strategic collaboration and non-exclusive licensing pact with EirGenix to advance integrated continuous biomanufacturing and expand global access to affordable biologics Princeton, New ...
Transcenta Therapeutics, a global biopharmaceutical company with capabilities in discovery, research, development and ...
Transcenta Holding Limited (HKEX: 06628) (“Transcenta Therapeutics”), a global clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and ...
Learn more about whether Charles River Laboratories International, Inc. or Danaher Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial ...
Maolac is not designed to imitate human milk, but to understand its biological advantages. Using a proprietary AI-driven ...
Explore how nanotechnology acts as the 'Convergence Engine' for AI materials discovery, CRISPR gene therapy delivery, and ...
Maintaining CDK4/6 inhibition constrains drug‑resistant breast tumors by delaying cell‑cycle entry, and adding CDK2 inhibition further deepens control to guide post‑progression therapy.
What defined pharma in 2025? Contract Pharma’s most‑viewed breaking news offers insights. Here’s your yearly recap—the most ...
The Hearty Soul on MSN
Children being hit by 'most severe flu outbreak' since 2010
Every start of the school year, particularly as the weather turns cool, cases of pediatric flu, aka flu in children, rise.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback